Page last updated: 2024-11-03

rimantadine and Hepatitis C

rimantadine has been researched along with Hepatitis C in 2 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffin, S2
Stgelais, C1
Owsianka, AM1
Patel, AH1
Rowlands, D2
Harris, M2
Wozniak, AL1
Yi, M1
Lemon, SM1
Weinman, SA1

Other Studies

2 other studies available for rimantadine and Hepatitis C

ArticleYear
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6

    Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Ce

2008
Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
    PLoS pathogens, 2010, Sep-02, Volume: 6, Issue:9

    Topics: Amantadine; Antifungal Agents; Antiviral Agents; Blotting, Western; Electroporation; Hepacivirus; He

2010